Author

Chi Wang

h-index 6 View on Semantic Scholar

We have 2 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Multiomics, pharmacogenomic, and structural characterization of NCCRP1 as a candidate therapeutic target in ovarian cancer.

The utility of integrating multiomics, pharmacogenomic, structural, and single-cell approaches for therapeutic target discovery and prioritization in cancer is demonstrated.

Dahlak Daniel Solomon, Yung-Kuo Lee, Sachin Kumar et al. · Naunyn-Schmiedeberg's Archiv... · 0 citations

Open access Aug 2026

Multi-level Transcriptomic and Machine-learning Analyses Identify MZT1 as a Proliferation-associated Prognostic Marker in Lung Adenocarcinoma

MZT1 is a proliferation-associated marker that integrates clinical risk, transcriptional programs, cellular heterogeneity, and predictive modeling in LUAD, providing a potential framework for biomarker development and risk stratification.

Dahlak Daniel Solomon, Hui-Ru Lin, Yung-Kuo Lee et al. · Cancer Genomics & Proteomics · 0 citations